Woodmere Art Museum extends Group 55 and Midcentury Modernism in Philadelphia exhibition
Sanford Greenberg, No. 24, 1955. Oil on canvas, 14 1/4 x 20 in. (Woodmere Art Museum: Museum purchase, 2014)
PHILADELPHIA, PA
.- In 1955, a group of Philadelphia painters, architects, musicians, and dancers organized a series of exhibitions and public forums across the city, presenting their work as a catalyst for vigorous public dialogue about the role of art and science in the postwar era. Group 55, as they came to be known, included architect Louis Kahn, composer George Rochberg, and artists Quita Brodhead, Michael Ciliberti, Sam Feinstein, Sam Fried, Sanford Greenberg, Raymond Hendler, Jane Piper, and Doris Staffel.
Credits: Photo: Sampson Wilcox/Research Laboratory of Electronics
Previous image
Next image
On Dec. 14, the Sanford and Susan Greenberg Prize to End Blindness honored 13 scientists who have made extraordinary headway in the worldwide battle against blindness. Among them was James G. Fujimoto, the Elihu Thomson Professor of Electrical Engineering within MIT’s Department of Electrical Engineering and Computer Science (EECS).
Recipients of the Greenberg Prize are honored in two categories: the Outstanding Achievement Prize, highlighting strides toward treating and curing blindness, and the Visionary Prize, providing funding for scientists whose research exhibits significant potential in ending this debilitating condition. Fujimoto, a principal investigator in the Research Laboratory of Electronics (RLE), was awarded the Visionary Prize for his research, which focuses upon the areas of biomedical imaging, optical coherence tomography, and advance
E-Mail
Three University of Pennsylvania researchers have been honored by The Sanford and Sue Greenberg Prize to End Blindness by 2020 for their research, which led to the first Food and Drug Administration-approved gene therapy for a genetic disease. Gustavo D. Aguirre of the School of Veterinary Medicine and Jean Bennett and Albert M. Maguire of the Perelman School of Medicine, together with William Hauswirth of the University of Florida, are recipients of the Outstanding Achievement Prize, awarded in a virtual ceremony.
The four scientists share a $1 million prize, funds that will go to support further laboratory and clinical research that advances vision science. Together, their work going from an animal model of disease to human clinical trials led to an FDA-approved gene therapy for Leber congenital amaurosis (LCA) caused by a mutation in the RPE65 gene, a retinal disease that causes visual impairments beginning in infancy. Now commercialized and used routinely, this treatme
Sandy Greenberg and his college roommate made a covenant 60-some years ago: If either was ever in real need, the other would have his back.
They were a couple of Jewish kids from upstate and downstate â Greenberg from Buffalo, his roommate from Queens â who hit it off from the moment they met as freshmen. Each would go on to landmark careers. And each has the other to thank for that.
When Greenberg went blind, in his junior year, his family begged him not to return to Columbia University. Amid the mad bustle of New York, they thought he would be hit by a bus or fall down a manhole. Greenberg believed he had no choice but to stay home in Buffalo, give up his full academic scholarship, and live a life of less.